Insulet (PODD) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $757.4 million.
- Insulet's Cash & Equivalents fell 1608.69% to $757.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $757.4 million, marking a year-over-year decrease of 1608.69%. This contributed to the annual value of $953.4 million for FY2024, which is 3538.77% up from last year.
- Per Insulet's latest filing, its Cash & Equivalents stood at $757.4 million for Q3 2025, which was down 1608.69% from $1.1 billion recorded in Q2 2025.
- Insulet's 5-year Cash & Equivalents high stood at $1.3 billion for Q1 2025, and its period low was $620.7 million during Q1 2023.
- Its 5-year average for Cash & Equivalents is $810.5 million, with a median of $757.4 million in 2025.
- As far as peak fluctuations go, Insulet's Cash & Equivalents skyrocketed by 30749.75% in 2021, and later plummeted by 1708.4% in 2022.
- Over the past 5 years, Insulet's Cash & Equivalents (Quarter) stood at $791.6 million in 2021, then dropped by 14.77% to $674.7 million in 2022, then increased by 4.37% to $704.2 million in 2023, then skyrocketed by 35.39% to $953.4 million in 2024, then decreased by 20.56% to $757.4 million in 2025.
- Its last three reported values are $757.4 million in Q3 2025, $1.1 billion for Q2 2025, and $1.3 billion during Q1 2025.